Benitec Biopharma Inc. has announced a 1-for-17 reverse stock split effective on July 26, 2023, subject to approval from The Nasdaq Capital Market. This action will transform every 17 shares of common stock issued and outstanding into one share of common stock, without altering stockholder's percentage interest in the company's equity.